Factor This Power Engineering
Live Events
DTECH® Events
POWERGEN™
INFOCAST Events
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
POWERGEN™
INFOCAST Events
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Edesa Biotech, Inc. - Common Shares
(NQ:
EDSA
)
12.91
-1.70 (-11.64%)
Streaming Delayed Price
Updated: 12:23 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edesa Biotech, Inc. - Common Shares
< Previous
1
2
3
4
5
6
Next >
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
October 12, 2023
Gainers
Via
Benzinga
Edesa Biotech Secures $10 Million Credit Facility with Company Founder
October 12, 2023
Via
ACCESSWIRE
Edesa Biotech to Receive Up To C$23 Million in Funding from Federal Government
October 12, 2023
Via
ACCESSWIRE
Edesa Biotech's Dermatitis Study Data Fails To Cheer Investors
↗
January 17, 2023
Via
Benzinga
Edesa Biotech Announces One-for-Seven Reverse Share Split
October 10, 2023
Via
ACCESSWIRE
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
September 28, 2023
Via
ACCESSWIRE
Edesa Biotech Reports Fiscal Third Quarter 2023 Results
August 09, 2023
Via
ACCESSWIRE
Edesa Biotech to Participate in Upcoming Canaccord Genuity Growth Conference
July 26, 2023
Via
ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
July 17, 2023
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday!
Via
InvestorPlace
Edesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In Preclinical Studies
↗
June 28, 2023
Edesa Biotech Inc (NASDAQ: EDSA) released findings from an in vitro study involving its monoclonal antibody candidate, paridiprubart.
Via
Benzinga
Edesa Biotech's ARDS Drug Inhibits Inflammation from Influenza and Other Pathogens
June 28, 2023
Via
ACCESSWIRE
Edesa Biotech Appoints Biotech Deal Veteran to CFO Role
June 27, 2023
Via
ACCESSWIRE
Edesa Biotech Reports Fiscal 2nd Quarter 2023 Results
May 11, 2023
Via
ACCESSWIRE
Edesa Biotech to Participate in Swiss Biotech Day
April 20, 2023
Via
ACCESSWIRE
The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate
April 04, 2023
Via
ACCESSWIRE
Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Disease Conference
March 23, 2023
Via
ACCESSWIRE
Edesa Biotech to Present Favorable Dermatitis Drug Results at American Academy of Dermatology Association Annual Meeting
March 16, 2023
Via
ACCESSWIRE
Edesa Biotech and FDA Agree on Primary Endpoint for Phase 3 ARDS Drug Study
March 15, 2023
Via
ACCESSWIRE
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results
February 10, 2023
Via
ACCESSWIRE
Edesa Biotech Receives Regulatory Approval for Phase 2 Vitiligo Study
February 01, 2023
Via
ACCESSWIRE
Why Arcimoto Shares Are Trading Lower By 44%; Here Are 20 Stocks Moving Premarket
↗
January 18, 2023
Gainers Siyata Mobile Inc. (NASDAQ: SYTA) rose 41.5% to $0.3255 in pre-market trading after gaining 8% on Tuesday.
Via
Benzinga
Nasdaq Edges Higher; Neovasc Shares Jump
↗
January 17, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Tuesday.
Via
Benzinga
Dow Tumbles 300 Points; Morgan Stanley Beats Q4 Views
↗
January 17, 2023
U.S. stocks traded mostly lower midway through trading, with the Dow Jones dropping over 300 points on Tuesday.
Via
Benzinga
Dow Drops Over 150 Points; Goldman Sachs Profit Misses Expectations
↗
January 17, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 150 points on Tuesday.
Via
Benzinga
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
January 17, 2023
Gainers Celyad Oncology SA (NASDAQ: CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program...
Via
Benzinga
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug
January 17, 2023
Via
ACCESSWIRE
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
↗
December 23, 2022
Gainers
Via
Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
↗
December 22, 2022
Gainers Core Scientific, Inc. (NASDAQ: CORZ) shares jumped 188% to $0.1471. Core Scientific shares dipped 75% on Wednesday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate
December 20, 2022
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
